Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5c6d5d7d68-wtssw Total loading time: 0 Render date: 2024-08-15T22:41:25.487Z Has data issue: false hasContentIssue false

Chapter 3 - Substance Use Assessment during Pregnancy

from Section 1 - Substance Use Disorders in Women and Pregnancy

Published online by Cambridge University Press:  08 June 2018

By
Jacquelyn Starer  and
Carl Christensen
Edited by
Tricia E. Wright
Tricia E. Wright
Affiliation:
University of Hawaii, Manoa
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Opioid-Use Disorders in Pregnancy
Management Guidelines for Improving Outcomes
 , pp. 19 - 26
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dowell, D. H. T, Chou, R. CDC guideline for prescribing opioids for chronic pain — United States, 2016. MMWR Recomm Rep 2016;65(No. RR-1):1–49. DOI: http://dx.doi.org/10.15585/mmwr.rr6501e1.Google Scholar
American Medical Association. Using Prescription Drug Monitoring Programs. Available from: www.ama-assn.org/content/using-prescription-drug-monitoring-programs.Google Scholar
National Association of Boards of Pharmacy. PMP Interconnect. Available from: https://nabp.pharmacy/initiatives/pmp-interconnect/.Google Scholar
Volkow, N., McLellan, T. Opioid abuse in chronic pain — misconceptions and mitigation strategies. The New England Journal of Medicine. 2016;374:1253–63.Google Scholar
Ewing, H. A Practical Guide to Intervention in Health and Social Services, with Pregnant and Postpartum Addicts and Alcoholics. Martinez, CA: The Born Free Project, Contra Costa County Department of Health Services; 1990.Google Scholar
Daetwyler, C., Schindler, B., Parran, T. The clinical assessment of substance use disorders. MedEdPORTAL 2012. Available from: https://webcampus.drexelmed.edu/nida/module_1/default_FrameSet.html.Google Scholar
Guidice, P. Cutaneous complications of intravenous drug use. The British Journal of Dermatology. 2004;150(1):1–10.CrossRefGoogle Scholar
Fiebach, N., Barker, L., Burton, J., Zieve, P. Principles of Ambulatory Medicine. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.Google Scholar
Bell, J., Towers, C. V., Hennessy, M. D., et al. Detoxification from opiate drugs during pregnancy. American Journal of Obstetrics and Gynecology. 2016;215(3):374. e1–6.CrossRefGoogle ScholarPubMed
Dennison, S. Clonidine abuse among opioid addicts. Psychiatric Quarterly. 2001;72:191.Google Scholar
Shapiro, B., Lynch, K., Toochinda, T., et al. Promethazine misuse among methadone maintenance patients and community-based injection drug users. Journal of Addiction Medicine. 2013;7(2):96–101.Google Scholar
Wilson, J., Jungner, G. Principles and Practice of Screening for Disease. Geneva: WHO; 1968. Available from: www.who.int/bulletin/volumes/86/4/07-050112BP.pdf.Google ScholarPubMed
Patient Testing: Ethical Issues in Selection and Counseling. ACOG Committee Opinion No. 363. American College of Obstetricians and Gynecologists. Obstetrics Gynecology. 2007;109:1021–3.Google Scholar
Skipper, G. E., Weinmann, W., Thierauf, A., et al. Ethyl glucuronide: A biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol and Alcoholism. 2004;39(5):445–9.Google Scholar
Mee-Lee, D., Schulman, G. D., Fishman, M. J., et al. The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, 3rd ed. Carson City, NV: The Change Companies; 2013.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×